| 今开：2.85 | 昨收：2.82 |
| 最高：3.07 | 最低：2.8201 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.0734094E7 |
Solid Biosciences(SLDB)04-28 04:48
$Solid Biosciences(SLDB)$ ARS Annual Report to Security Holders Accession Number: 0000950170-23-015342 Act: 34 Size: 4 MB 网页链接查看全文
Solid Biosciences(SLDB)04-28 04:33
$Solid Biosciences(SLDB)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-23-015304 Act: 34 Size: 4 MB 网页链接查看全文
Solid Biosciences(SLDB)03-20 19:36
$Solid Biosciences(SLDB)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-23-074426 Act: 34 Size: 755 KB 网页链接查看全文
Solid Biosciences(SLDB)03-13 19:36
$Solid Biosciences(SLDB)$ 8-K Current report, item 7.01 Accession Number: 0001193125-23-068478 Act: 34 Size: 146 KB 网页链接查看全文
Solid Biosciences(SLDB)03-07 10:27
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-007270 Size: 9 KB 网页链接查看全文
Solid Biosciences(SLDB)02-13 21:51
$Solid Biosciences(SLDB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-23-000936 Act: 34 Size: 107 KB 网页链接查看全文
Solid Biosciences(SLDB)02-14 05:48
$Solid Biosciences(SLDB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001461790-23-000010 Act: 34 Size: 106 KB 网页链接查看全文
Solid Biosciences(SLDB)02-10 19:06
$Solid Biosciences(SLDB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-23-000090 Act: 34 Size: 47 KB 网页链接查看全文
Solid Biosciences(SLDB)02-07 19:12
$Solid Biosciences(SLDB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000289 Act: 33 Size: 1 KB 网页链接查看全文
Solid Biosciences(SLDB)02-04 05:42
$Solid Biosciences(SLDB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-23-024221 Act: 34 Size: 74 KB 网页链接查看全文
美股滚雪球01-12 12:19
$Solid Biosciences(SLDB)$ 和Phlox Therapeutics达成战略合作，开发针对遗传性心脏病的精准药物。这项研究合作将针对一种严重的遗传性扩张型心肌病(DCM)。
这项战略合作将整合Solid的载体生物学、制造能力和药物开发经验，以及Phlox在遗传心肌病和RNA治疗方面的专业知识。
两家公司表示，...查看全文
牛唐2022-10-03 15:50
医药板块速评（2022.09.30）
本期内容提示：
1、美股大盘跌跌不休，是否有抄底机会？$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发，是否有机会跟仓？
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
美股滚雪球2022-10-02 22:24
$Solid Biosciences(SLDB)$ 宣布收购基因治疗公司AavantiBio，旨在推进一系列神经肌肉和心脏项目，预计四季度完成合并。
交易完成后，AavantiBio现任首席执行官Bo Cumbo将担任Solid Biosciences的总裁兼首席执行官。
为支持此次收购，SLDB已与一些选定的机构投资者和合格投资者达成了一项...查看全文
$Solid Biosciences(SLDB)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-23-277552 Act: 34 Size: 176 KB 网页链接
$Solid Biosciences(SLDB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-061096 Act: 34 Size: 8 MB 网页链接
$Solid Biosciences(SLDB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-054381 Size: 15 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-054388 Size: 7 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-052171 Size: 7 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-046760 Size: 9 KB 网页链接
$Solid Biosciences(SLDB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042371 Act: 34 Size: 9 MB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031954 Size: 7 KB 网页链接
$Solid Biosciences(SLDB)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001193125-23-164486 Act: 34 Size: 163 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-015008 Size: 5 KB 网页链接